Wedbush Securities’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-13,889
Closed -$56K 844
2016
Q4
$56K Buy
+13,889
New +$56K 0.01% 773